Publicaties
- pdf
Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA) Part II – EQA cycles
Buchta C, Marrington R, De la Salle B, Albarède S, Badrick T, Berghäll H, Bullock D, Coucke W, Delatour V, Geilenkeuser WJ, Griesmacher A, Henriksen GM, Huggett JF, Luppa PB, Pelanti J, Pezzati P, Sandberg S, Spannagl M, Thelen M, Restelli V, Perrone LA. Behind the scenes of EQA - characteristics, capabilities, benefits and assets of external quality assessment (EQA). Clin Chem Lab Med. 2025 Jan 6. doi: 10.1515/cclm-2024-1290. Epub ahead of print. PMID: 39753241. - pdf
Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA) Part III – EQA samples
Buchta C, Marrington R, De la Salle B, Albarède S, Albe X, Badrick T, Berghäll H, Bullock D, Cobbaert CM, Coucke W, Delatour V, Geilenkeuser WJ, Griesmacher A, Henriksen GM, Huggett JF, Juhos I, Kammel M, Luppa PB, Meijer P, Pelanti J, Pezzati P, Sandberg S, Spannagl M, Thelen M, Thomas A, Zeichhardt H, Restelli V, Perrone LA. Behind the scenes of EQA - characteristics, capabilities, benefits and assets of external quality assessment (EQA). Clin Chem Lab Med. 2025 Jan 6. doi: 10.1515/cclm-2024-1291. Epub ahead of print. PMID: 39753204. - pdf
Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA) Part IV - Benefits for participant laboratories
Buchta C, De la Salle B, Marrington R, Albarède S, Badrick T, Bicker W, Bietenbeck A, Bullock D, Delatour V, Dequeker E, Flasch M, Geilenkeuser WJ, van Hellemond J, Huggett JF, Ianovska V, Kaiser P, Kammel M, Kessler A, Laudus N, Luppa PB, Morandi PA, O'Connor G, Panteghini M, Pezzati P, Rosendahl J, Sandberg S, Scheiblauer H, Skitek M, Spannagl M, Stavelin A, Thelen M, Unterberger U, Zeichhardt H, Restelli V, Perrone LA. Behind the scenes of EQA-characteristics, capabilities, benefits and assets of external quality assessment (EQA). Clin Chem Lab Med. 2025 Jan 6. doi: 10.1515/cclm-2024-1292. Epub ahead of print. PMID: 39754494. - pdf
Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA) Part V –Benefits for stakeholders other than participants
Buchta C, De la Salle B, Marrington R, Aburto Almonacid A, Albarède S, Badrick T, Bullock D, Cobbaert CM, Coucke W, Delatour V, Faria AP, Geilenkeuser WJ, Griesmacher A, Huggett JF, Ianovska V, Kammel M, Kessler A, Körmöczi GF, Meijer P, Miranda A, Patel D, Pezzati P, Sandberg S, Schennach H, Schweiger CR, Schwenoha K, Spannagl M, Sung H, Thelen M, Weykamp C, Zeichhardt H, Restelli V, Perrone LA. Behind the scenes of EQA - characteristics, capabilities, benefits and assets of external quality assessment (EQA). Clin Chem Lab Med. 2025 Jan 6. doi: 10.1515/cclm-2024-1293. Epub ahead of print. PMID: 39753240. - pdf
EN ISO 15189 revision EFLM Committee Accreditation and ISOCEN standards CAISO analysis and general remarks on the changes
Linko S, Boursier G, Bernabeu-Andreu FA, Dzneladze N, Vanstapel F, Brguljan PM, Tosheska-Trajkovska K, Mehay H, Panteghini M, Brugnoni D, Milinkovic N, Lohmander M, Šprongl L, Çubukçu HC, Thelen M. EN ISO 15189 revision: EFLM Committee Accreditation and ISO/CEN standards (C: A/ISO) analysis and general remarks on the changes. Clin Chem Lab Med. 2025 Jan 6;63(6):1084-1098. doi: 10.1515/cclm-2024-1451. PMID: 39752732. - pdf
Equivalence in clinical assessment of iron status requires ferritin assay standardisation before harmonisation of ferritin reference intervals-Swinkels
Swinkels DW, van Schrojenstein Lantman M, Matlung HL, Weykamp C, Thelen M. Equivalence in clinical assessment of iron status requires ferritin assay standardisation before harmonisation of ferritin reference intervals. Lancet Haematol. 2024 Oct;11(10):e721. doi: 10.1016/S2352-3026(24)00245-X. PMID: 39362739. - pdf
External quality assessment-based tumor marker harmonization simulation; insights in achievable harmonization for CA 15-3 and CEA - Van Rossum
Van Rossum HH, Holdenrieder S, Yun YM, Patel D, Thelen M, Song J, Unsworth N, Partridge K, Moore M, Cui W, Ramanathan L, Meng QH, Ballieux BEPB, Sturgeon C, Vesper H. External quality assessment-based tumor marker harmonization simulation; insights in achievable harmonization for CA 15-3 and CEA. Clin Chem Lab Med. 2024 Sep 20. doi: 10.1515/cclm-2024-0696. Epub ahead of print. PMID: 39299928. - pdf
Clinical Decision-Making Suffers from Inequivalent Measurement Results and Inadequate Reference Intervals -van Schrojenstein Lantman
van Schrojenstein Lantman M, van Berkel M, Kuijper P, Langelaan M, Brouwer N, Thelen M. Clinical Decision-Making Suffers from Inequivalent Measurement Results and Inadequate Reference Intervals. Clin Chem. 2024 Sep 17:hvae129. doi: 10.1093/clinchem/hvae129. Epub ahead of print. PMID: 39288014. - pdf
Analytical performance specifications for trace elements in biological fluids derived from six countries federated external quality assessment schemes over 10 years
Arnaud J, Weykamp C, Wenzel R, Patriarca M, González-Estecha M, Janssen L, Fofou-Caillierez MB, Alemany MV, Patriarca V, de Graaf I, Persoons R, Panadès M, China B, Winkel MT, van der Vuurst H, Thelen M. Analytical performance specifications for trace elements in biological fluids derived from six countries federated external quality assessment schemes over 10 years. Clin Chem Lab Med. 2024 Jul 22. doi: 10.1515/cclm-2024-0551. Epub ahead of print. PMID: 39027966. - pdf
Modelling the impact of bias in fecal immunochemical testing on long-term outcomes of colorectal cancer screening
de Jonge L, Toes-Zoutendijk E, Koopmann BDM, van Schrojenstein Lantman M, Franken-van Vorsselen B, Speijers C, van Ingen H, Humer E, van der Groep P, Thelen M, Lansdorp-Vogelaar I; Dutch National Colorectal Cancer Screening Working Group. Modelling the impact of bias in fecal immunochemical testing on long-term outcomes of colorectal cancer screening. Clin Chim Acta. 2024 Jul 15;561:119809. doi: 10.1016/j.cca.2024.119809. Epub 2024 Jun 13. PMID: 38879061.
2025
2024